Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

Overview | Financials
Company Name Regeneron Pharmaceuticals, Inc.
Symbol REGN
Currency USD
Price 666.87
Market Cap 71,693,859,960
Dividend Yield 0%
52-week-range 642 - 1,211.2
Industry Biotechnology
Sector Healthcare
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Website https://www.regeneron.com

An error occurred while fetching data.

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following

Related Stocks

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

484.44 USD

Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILD

111.44 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

504.77 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

34.62 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

85.6 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.23 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Biogen Inc. logo

Biogen Inc.

BIIB

139.44 USD

Financials

Numbers are in millions USD

Numbers are in millions USD